X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26) 26
index medicus (22) 22
male (20) 20
middle aged (20) 20
female (19) 19
adult (16) 16
aged (13) 13
abridged index medicus (9) 9
diagnosis (9) 9
cardiac & cardiovascular systems (7) 7
peripheral vascular disease (7) 7
retrospective studies (7) 7
vasculitis (7) 7
young adult (7) 7
adolescent (6) 6
disease (6) 6
hematology (6) 6
risk factors (6) 6
biopsy (5) 5
takayasu arteritis (5) 5
treatment outcome (5) 5
care and treatment (4) 4
child (4) 4
mortality (4) 4
phenotype (4) 4
prevalence (4) 4
rheumatology (4) 4
surgery (4) 4
therapy (4) 4
acute interstitial nephritis (3) 3
acute renal failure (3) 3
age (3) 3
aged, 80 and over (3) 3
atherosclerosis (3) 3
back pain (3) 3
c-reactive protein - analysis (3) 3
case-control studies (3) 3
criteria (3) 3
disease-free survival (3) 3
immunology (3) 3
inflammation (3) 3
malakoplakia (3) 3
management (3) 3
parkinson's disease (3) 3
patients (3) 3
peripheral artery disease (3) 3
prognosis (3) 3
proportional hazards models (3) 3
takayasu arteritis - complications (3) 3
takayasu arteritis - drug therapy (3) 3
takayasu's arteritis (3) 3
activation (2) 2
amn107 (2) 2
amputation (2) 2
analysis (2) 2
angiography (2) 2
animals (2) 2
anti-inflammatory agents - therapeutic use (2) 2
anticoagulants (2) 2
antirheumatic agents - therapeutic use (2) 2
arterial stiffness (2) 2
arteritis (2) 2
atrial fibrillation (2) 2
betablockers (2) 2
bicuspid aortic valve (2) 2
blood sedimentation (2) 2
bone marrow (2) 2
cells (2) 2
cholesterol (2) 2
classification (2) 2
cohort (2) 2
collagen (2) 2
complications and side effects (2) 2
cross-sectional studies (2) 2
diagnosis, differential (2) 2
disease-activity (2) 2
drug therapy, combination (2) 2
ehlers-danlos syndrome (2) 2
endothelial cells (2) 2
epidemiology (2) 2
etanercept (2) 2
follow-up (2) 2
gene (2) 2
glucocorticoids - therapeutic use (2) 2
haemostasis disorders (2) 2
health aspects (2) 2
imatinib (2) 2
immunosuppressive agents - administration & dosage (2) 2
immunosuppressive agents - therapeutic use (2) 2
infections (2) 2
infliximab (2) 2
kaplan-meier estimate (2) 2
life sciences (2) 2
liver cirrhosis - complications (2) 2
lowe syndrome (2) 2
magnetic resonance imaging (2) 2
marfan-syndrome (2) 2
medicine, general & internal (2) 2
methods (2) 2
methotrexate (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


La Revue du praticien, ISSN 0035-2640, 04/2015, Volume 65, Issue 4, p. 561
Journal Article
La Revue du praticien, ISSN 0035-2640, 04/2015, Volume 65, Issue 4, pp. 561 - 568
Journal Article
Journal Article
La Presse Médicale, ISSN 0755-4982, 07/2017, Volume 46, Issue 7-8, pp. e189 - e196
Takayasu arteritis (TAK) is a vasculitis of the large arteries. The arterial wall, target of the immune reaction, is composed of vascular dendritic cells,... 
Journal Article
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ISSN 0735-1097, 04/2019, Volume 73, Issue 15, pp. 1948 - 1957
Journal Article
FRONTIERS IN PHYSIOLOGY, ISSN 1664-042X, 04/2019, Volume 10, p. 299
Journal Article
La Presse Médicale, ISSN 0755-4982, 07/2017, Volume 46, Issue 7-8, pp. e189 - e196
Journal Article
Presse Medicale, ISSN 0755-4982, 10/2012, Volume 41, Issue 10, pp. 975 - 985
Thorough clinical and imaging assessment of the arterial tree when a diagnosis of Takayasu arteritis is established.Glucocorticoïd as intiation... 
Journal Article
La Presse Medicale, ISSN 0755-4982, 10/2012, Volume 41, Issue 10, pp. 975 - 985
. . . . . . . . . . . . 
Journal Article
European Journal of Haematology, ISSN 0902-4441, 04/2015, Volume 94, Issue 4, pp. 363 - 367
The second‐generation tyrosine kinase inhibitor ( TKI ) of the BCR ‐ ABL 1 oncoprotein nilotinib used in patients with chronic myeloid leukemia is suspected to... 
BCR | leukemia myelogenous chronic | arterial occlusive diseases | nilotinib | peripheral arterial disease | ABL | positive | pharmacovigilance | Nilotinib | Peripheral arterial disease | Arterial occlusive diseases | Pharmacovigilance | Leukemia myelogenous chronic BCR-ABL positive | RISK-FACTORS | OCCLUSIVE DISEASE | VASCULAR EVENTS | PREVALENCE | THERAPY | IMATINIB | RESISTANCE | TYROSINE KINASE INHIBITOR | AMN107 | leukemia myelogenous chronic BCR-ABL positive | HEMATOLOGY | Peripheral Arterial Disease - etiology | Angiography | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Patient Outcome Assessment | Protein Kinase Inhibitors - adverse effects | Fusion Proteins, bcr-abl - genetics | Peripheral Arterial Disease - diagnosis | Antineoplastic Agents - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Fusion Proteins, bcr-abl - antagonists & inhibitors | Pyrimidines - adverse effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications | Drug Substitution | Antimitotic agents | Development and progression | Chronic myeloid leukemia | Antineoplastic agents | Patient outcomes | Cardiac patients
Journal Article
Circulation, ISSN 0009-7322, 02/2012, Volume 125, Issue 6, pp. 813 - 819
Journal Article
Autoimmunity Reviews, ISSN 1568-9972, 2011, Volume 11, Issue 9, pp. 678 - 684
Abstract Takayasu arteritis (TA) is a rare large vessels vasculitis. Conventional therapy consists of glucocorticoids which may be associated with other... 
Allergy and Immunology | Anti TNF-α | Immunosuppressants | Vasculitis | Takayasu's arteritis | Anti TNF-alpha | CELLS | RESISTANT | CROHNS-DISEASE | METHOTREXATE | PATIENT | IMMUNOLOGY | NECROSIS FACTOR THERAPY | INFLIXIMAB THERAPY
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2019, Volume 73, Issue 15, pp. 1948 - 1957
Journal Article